Community-acquired pneumonia (CAP) is the leading cause of death among infectious
diseases and an important health problem, having considerable implications for healthcare …

Background Community-acquired pneumonia (CAP) guidelines have improved the
treatment and outcomes of patients with CAP, primarily by standardization of initial empirical …

Background: This document provides evidence-based clinical practice guidelines on the
management of adult patients with community-acquired pneumonia. Methods: A …

Purpose Severe community-acquired pneumonia (sCAP) is associated with high morbidity
and mortality, and whilst European and non-European guidelines are available for …

Pseudomonas aeruginosa is an important opportunistic human pathogen. Using its arsenal
of virulence factors and its intrinsic ability to adapt to new environments, P. aeruginosa …

Community-acquired pneumonia (CAP) is the prominent cause of mortality and morbidity
with important clinical impact across the globe. India accounts for 23 per cent of global …

Purpose Severe community-acquired pneumonia (SCAP) is still associated with substantial
morbidity and mortality. In this point-of-view review paper, a group of experts discuss the …

Community-acquired pneumonia (CAP) is associated with high morbidity and mortality
worldwide [1]. Although several different bacteria and respiratory viruses can be responsible …

Antimicrobial coatings can be used to reduce the transmission of infectious agents that are
spread by contact. An effective coating should kill microbes in the time between users, which …

Intensive care units (ICUs) are an appropriate focus of antibiotic stewardship program efforts
because a large proportion of any hospital's use of parenteral antibiotics, especially broad …